Serum vascular endothelial growth factor-A levels during induction therapy in children with acute lymphoblastic leukemia

Indian Pediatrics

Volumn 50, Issue 7, 2013, Pages 659-662

  Kalra, Manas ^a   Dinand, Veronique ^a   Choudhary, Sangeeta ^a   Sachdeva, Anupam ^a   Yadav, Satya Prakash ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

Angiogenesis; hematological malignancy; VEGF

Indexed keywords

LACTATE DEHYDROGENASE; VASCULOTROPIN 165; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; LEUKEMIA CELL; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MALE; PEDIATRIC HOSPITAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TUMOR VOLUME; BLOOD; CASE CONTROL STUDY; INFANT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84880309389     PISSN: 00196061     EISSN: 09747559     Source Type: Journal    
DOI: 10.1007/s13312-013-0198-6     Document Type: Article

References (14)

1. Koomagi R, Zintl F, Sauerbrey, Volm M. Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction. Clin Cancer Res. 2001;7:3381-3384.
2. Podar K, Anderson KC. The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood. 2005;105:1383-1395.
3. Homsi J, Daud AI. Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors. Cancer Control. 2007;14:285-294.
4. Yetgin S, Yenicescu I, Cetin M, Tuncer M. Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2001;42:83-88.
5. Aref S, Salama O, Shamaa S, El-Refaie M, Mourkos H. Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia. Hematology. 2007;12:319-324.
6. Hu Q, Dey AL, Yang Y, Shen Y, Jilani IB, Estey EH, et al. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes. Cancer. 2004;100:1884-1891.
7. Albitar M, Do KA, Johnson MM, Giles FJ, Jilani I, O'Brien S, et al. Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implications in therapy with anti-CD52 antibodies. Cancer. 2004;101:999-1008.
8. Giles FJ, Vose JM, Do KA, Johnson MM, Manshouri T, Bociek G, et al. Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma. Leuk Res. 2004;28:595-604.
9. Bellamy WT, Richter L, Frutiger Y, Grogan TM. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res. 1999;59:728-733.
10. Baruchel S, Wu B, Mokhtari RB, Glade Bender JL, DuBois SG, Widemann BC, et al. Surrogate biomarkers of antiangiogenesis in Children's Oncology Group (COG) phase I trials. J Clin Oncol. 2011;29:585.
11. Yang HQ, Zhang RH, Zhang ZH, Wan CC, Xia YJ. Plasma concentrations of vascular endothelial growth factor and tissue factor in children with acute lymphoblastic leukemia. Zhongguo Dang Dai Er Ke Za Zhi. 2007;9:526-528.
12. Avramis IA, Panosyan EH, Dorey F, Holcenberg JS, Avramis VI. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: A Report from Children's Oncology Group Study CCG-1962. Clin Cancer Res. 2006;12:6978-6984.
13. Schneider P, Vasse M, Legrand E, Callat MP, Vannier JP. Have urinary levels of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, a prognostic value in childhood acute lymphoblastic leukaemia? Br J Haematol. 2003;122:163-164.
14. Aguayo A, Estey E, Kantarjian H, Mansouri T, Gidel C, Keating M, et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood. 1999;94:3717-3721.